Official government website of the Government of the Kingdom of Saudi Arabia How to verify

Links to official Saudi educational websites end with edu.sa

All links to official educational websites of government agencies in Saudi Arabia end with .edu.sa.

protocol for encryption and security. HTTPS for encryption and security.

Secure websites in the Kingdom of Saudi Arabia use the HTTPS protocol for encryption.

Registered with the Digital Government Authority with no: 20250413538

Colleges

Section list

Integrated drug therapy: Hematology/Oncology

Course Description: This course aims to integrate the pathophysiological abnormalities of hematological and oncological diseases with the concepts of drug action and therapy. Pharmacotherapy will be reviewed with a focus on pathophysiology, pharmacology, pharmaceutics, and medicinal chemistry. Emphasis will also be placed on drug selection, dosage regimen design, and therapeutic drug monitoring to assess the achievement of therapeutic efficacy and avoid adverse effects.

Credit hours: 4

Prerequisites: 251 PHP

Objectives of the course :

The main goals of the course:
Upon successful completion of this course, students will be able to:
1. Describe the pathophysiological processes of hematological/oncological disorders.
2. Explain the pharmacology of drugs used to treat blood disorders/cancers.
Describe the relationships between the structural activity of drugs used to treat blood disorders/tumors.
4. Describe drug dosage formulations used in the treatment of blood/oncological disorders.
5. Provide the necessary therapeutic knowledge for managing patients with hematology/oncology disorders.
6. Describe appropriate pharmacological and non-pharmacological treatments. 7. Discuss logical, reasonable, and practical solutions to problems related to medications.
8. Describe the desired outcomes of drug therapy.
9. Present a plan to monitor drug efficacy, side effects, adherence, and drug interactions for patients treated with medications.

Course outputs :

Knowledge and Understanding
Describe the pathophysiology, risk factors, complications, and clinical presentation of hematologic/oncologic disorders.
Explain the relationship between metabolism and the structural activity of drugs used to treat blood disorders/tumors.
Describe the routes of administration and dosage forms for drugs used in the treatment of blood disorders/cancers.
Explain the pharmacology of drugs used in the treatment of hematologic malignancies.
Recognize the role of pharmacists in promoting health, prevention, and treatment in accordance with legal, ethical, and professional standards.
2- Skills:
Identifying and prioritizing therapeutic alternatives to personalize treatment regimens for each patient.
* Identify drug-related problems associated with the management of patients with hematologic/oncologic disorders.
Monitoring therapeutic outcomes and side effects of drug therapy used in managing patients with hematologic/oncologic disorders.
Design a care plan appropriate for managing a patient with various blood disorders and malignancies.
3- Values, Independence, and Responsibility:
Demonstrate the ability to work as part of a team.
Demonstrates self-learning ability.

Additional information:

Last updated: 2026-05-14